Original articleAcquired deficiency of the inhibitor of the first component of complement: Report of five additional cases with commentary on the syndrome☆
References (29)
- et al.
Acquired C1 deficiency in lymphosarcoma
Clin Immunol Immunopathol
(1972) - et al.
A biochemical abnormality in hereditary angioneurotic edema: absence of serum inhibitor of C'1 esterase
Am J Med
(1963) - et al.
Acquired angioedema with lymphoproliferative disorder: association of C1 inhibitor deficiency with cellular abnormality
Blood
(1976) - et al.
Acquired angioedema associated with rectal carcinoma and its response to danazol therapy
J Allergy Clin Immunol
(1978) - et al.
Expression of human B cell-associated antigens on leukemias and lymphomas: a model of human B cell differentiation
Blood
(1984) - et al.
Clinical/biochemical assessment of acquired CINH deficiency
J Allergy Clin Immunol
(1983) - et al.
Clinical and biochemical effects of stanozolol therapy for hereditary angioedema
J Allergy Clin Immunol
(1981) - et al.
Action of complement in hereditary angioneurotic edema: the role of C'1 esterase
J Clin Invest
(1964) - et al.
Natural control mechanisms of the complement system
- et al.
Evidence for immune complexes involving antilymphocyte antibodies associated with hypocomplementemia in chronic lymphocytic leukemia (CLL)
Clin Exp Immunol
(1976)
Angioedema and hypocomplementemia
J Allergy Clin Immunol
(1975)
Acquired C1 inhibitor deficiencies in lymphoproliferative diseases with serum immunoglobulin abnormalities: a study of three cases
Blut
(1976)
Treatment of acquired C1 inhibitor deficiency with danazol
Ann Intern Med
(1977)
Diffuse normolipaemic plane xanthomatosis, an abnormal complement component profile
Clin Exp Immunol
(1974)
Cited by (0)
- ☆
Supported by grants AI-22531, AI-10356, AI-17917, HL-17382, AM-05577, RR-02172, and RR-05669 from the National Institutes of Health.
Copyright © 1985 Published by Mosby, Inc.